🇺🇸 PI in United States
30 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 30
Most-reported reactions
- Neutrophil Count Decreased — 4 reports (13.33%)
- Vomiting — 4 reports (13.33%)
- Arrhythmia — 3 reports (10%)
- Drug Ineffective — 3 reports (10%)
- Myelosuppression — 3 reports (10%)
- Nausea — 3 reports (10%)
- Neutropenia — 3 reports (10%)
- Pneumonia — 3 reports (10%)
- Abdominal Discomfort — 2 reports (6.67%)
- Acute Kidney Injury — 2 reports (6.67%)
Other Virology/Infectious Disease approved in United States
Frequently asked questions
Is PI approved in United States?
PI does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for PI in United States?
Hoffmann-La Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.